Revaprazan

Revaprazan
Clinical data
Trade names	Revanex
Other names	YH1885
ATC code	None;
Identifiers
	IUPAC name N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine;
CAS Number	199463-33-7;
PubChem CID	204104;
ChemSpider	176801;
UNII	5P184180P5;
CompTox Dashboard (EPA)	DTXSID10870216 ;
Chemical and physical data
Formula	C22H23FN4
Molar mass	362.452 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c1cc(F)ccc1Nc2nc(C)c(C)c(n2)N3CCc4ccccc4C3C;
	InChI InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26); Key:LECZXZOBEZITCL-UHFFFAOYSA-N;

Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis.^[2] It acts as an acid pump antagonist^[3] (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea,^[4] but is not approved in Europe or the United States.

Trade namesRevanex^[1]

Other namesYH1885

ATC code

None

CAS Number

199463-33-7

Quick facts Clinical data, Trade names ...

Close

[2]

[3]

[4]

[1]

Revaprazan

See also

References

Related Articles

Clinical data

Trade names	Revanex^[1]
Other names	YH1885
ATC code	None
Identifiers
IUPAC name N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine
CAS Number	199463-33-7
PubChem CID	204104
ChemSpider	176801
UNII	5P184180P5
CompTox Dashboard (EPA)	DTXSID10870216
Chemical and physical data
Formula	C₂₂H₂₃FN₄
Molar mass	362.452 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES c1cc(F)ccc1Nc2nc(C)c(C)c(n2)N3CCc4ccccc4C3C
InChI InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26) Key:LECZXZOBEZITCL-UHFFFAOYSA-N